The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
Fig 1
Percent reduction in SARS-COV-2 cases at the epidemic peak for various reductions in the average infectious period duration when treating various proportions of symptomatic and all infected cases with a reproductive rate (R0) of A) 2.0, when starting treatment after 5% of the population has been exposed, B) 2.0, when starting treatment after 15% of the population has been exposed, C) 2.5, when starting treatment after 5% of the population has been exposed, D) 2.5, when starting treatment after 15% of the population has been exposed, E) 3.5, when starting treatment after 5% of the population has been exposed, and F) 3.5, when starting treatment after 15% of the population has been exposed.